missing translation for 'onlineSavingsMsg'
Learn More

PD173074, MedChemExpress

Product Code. 16474856
Encompass_Preferred
Click to view available options
Quantity:
10 mg
50 mg
100 mg
200 mg
Unit Size:
100mg
10mg
200mg
50mg
This item is not returnable. View return policy

Product Code. 16474856

Brand: Medchem Express HY10321

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress PD173074 is a potent FGFR1 inhibitor with an IC50 of 25 nM and also inhibits VEGFR2 with an IC50 of 100-200 nM, showing 1000-fold selectivity for FGFR1 over PDGFR and c-Src.

PD173074 is a potent FGFR1 inhibitor with an IC50 of 25 nM and also inhibits VEGFR2 with an IC50 of 100-200 nM, showing 1000-fold selectivity for FGFR1 over PDGFR and c-Src.

Specifications

Chemical Name or Material PD173074
CAS 219580-11-7
Color Off-White
Purity Grade Notes Research
Molecular Formula C28H41N7O3
Quantity 100 mg
Solubility Information DMSO : ≥ 52 mg/mL (99.30 mM)
SMILES O=C(NC1=NC2=NC(NCCCCN(CC)CC)=NC=C2C=C1C3=CC(OC)=CC(OC)=C3)NC(C)(C)C
Molecular Weight (g/mol) 523.67
Formula Weight 523.67
Percent Purity 98.39%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.